Skip to main content
. 2023 Jan 13;13(2):304. doi: 10.3390/diagnostics13020304

Figure 1.

Figure 1

Therapeutical agents used in CHF management and their pathogenic mechanisms. ARB, angiotensin receptor blockers. ACE, angiotensin-converting enzyme. AcSDKP, N-Acetyl-Seryl-Aspartyl-Lysyl-Proline. ↑ = elevated value.